ActivitiesCVD PreventionEarly Detection

Early Detection

To reduce the onset of cardiovascular disease (CVD), it is crucial to identify those persons at high risk of developing CVD and to provide them with appropriate advice and preventive treatment. Policymakers should focus on implementing strategies for prevention at an individual level and early identification of so-called high-risk individuals; that is, people who are at high risk of developing or dying from cardiovascular disease.

EHN advocates for the implementation of evidence-based policies, measures and programmes for reaching out to and managing high-risk individuals for CVD in Europe, and to detect those with treatable cardiovascular conditions.

To learn more, read EHN’s revised publication on early detection and CVD below. It builds upon available evidence from several studies and evidence gathered by experts as part of the WHO’s initiative on screening, published in the WHO Health Evidence Network (HEN) report, What is the effectiveness of systematic population level screening programmes for reducing the burden of cardiovascular disease?, which synthesizes several high-quality, randomised controlled trials.